Ashland Gains EXCiPACT Certification for Excipients Site
By

By
Ashland Specialities France, a subsidiary of Ashland Global Holdings, has been granted an EXCiPACT certificate by the Société Générale de Surveillance, a Hamburg, Germany-based certifying body of EXCiPACT, for Ashland’s…

Lannett Expands Controlled Substances Facilities
By

By
Lannett, a Philadelphia-headquartered generic drug manufacturer, has announced that it will invest $50 million to expand the facilities of Cody Laboratories, its Cody, Wyoming-headquartered wholly owned subsidiary and a manufacturer…

Sanofi, Regeneron Win Temporary Reprieve in Patent-Infringement Battle with Amgen
By

By
The United States Court of Appeals for the Federal Circuit has stayed a permanent injunction for Sanofi’s and Regeneron Pharmaceuticals’ Praluent (alirocumab), an anti-cholesterol drug, a proprotein convertase subtilisin/kexin type 9…

FTC Files Civil Action Against Shire Subsidiary For Generic Antibiotic Delay
By

By
The US Federal Trade Commission (FTC) has filed a civil action in federal district court against Shire ViroPharma, a wholly owned subsidiary of Shire, related to citizen petitions submitted by…

Porton to Acquire J-Star in $26-Million Deal
By

By
Porton Fine Chemicals, a Chongqing, China-headquartered contract development and manufacturing organization (CDMO), has entered into a stock purchase agreement through its wholly owned subsidiary, Porton USA, with the shareholders of…

KBI Acquires Cell Therapy Manufacturing Plant
By

By
KBI Biopharma, a Durham, North Carolina-headquartered biopharmaceutical contract development and manufacturing organization, has acquired the manufacturing and laboratory assets of Opexa Therapeutics, a biotechnology company based in The Woodlands, Texas, which…

Camargo in Drug Delivery, Regulatory Consulting Deal
By

By
Camargo Pharmaceutical Services, a Cincinnatti, Ohio-based provider of drug development services, has entered into a service agreement with Cocoon Biotech, a Boston-based biotechnology company focused on silk protein-based drug delivery…

Enteris, Ferring in Oral Peptide Deal
By

By
Ferring Pharmaceuticals, headquartered in Saint-Prex, Switzerland, has entered into a licensing agreement and initiated an early development agreement with Enteris BioPharma, a Boonton, New Jersey-headquartered biotechnology company that specializes in…

Arven, GE Partner for Biomanufacturing
By

By
Arven Pharmaceuticals, a Toksoz Group Company headquartered in Istanbul, Turkey, is expanding its cell-line production capacity at its facility in Kirklareli, Turkey, using GE Healthcare’s FlexFactory manufacturing platform, which is…

GE in Cell Line Engineering Pact
By

By
GE Healthcare has formed a three-year research partnership with the Austrian Centre of Industrial Biotechnology (acib) for developing cell-line engineering that will bring increased productivity for biomanufacturing. The goal of…